Safety and Efficacy of Autologous or Donor-derived CD19 CAR-T Treatment in Relapsed B Acute Lymphocytic Leukemia after Allo-HSCT

被引：0
|
作者：
Zhang, Xian [1 ]
Lu, Xin-An [2 ]
Xiong, Min [1 ]
Yang, Jun-Fang [1 ]
Zhang, Jian-Ping [1 ]
Zhou, Xiao-Su [1 ]
He, Ting [2 ]
Lu, Pei-Hua [1 ]
机构：
[1] Hebei Yanda Ludaopei Hosp, Langfang, Peoples R China
[2] Immuno China Pharmaceut Co Ltd, Beijing, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O144
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [1] Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy
    Kong, Delin
    Yang, Tingting
    Geng, Jia
    Jing, Ruirui
    Zhang, Qiqi
    Wei, Guoqing
    Huang, He
    Hu, Yongxian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (10): : 876 - 880
  • [2] Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia
    Dourthe, Marie Emilie
    Yakouben, Karima
    David, Audrey
    Thouvenin, Sandrine
    Chaillou, Delphine
    Caillat-Zucman, Sophie
    Cuffel, Alexis
    Tardy, Clea
    Lainey, Elodie
    Caye-Eude, Aurelie
    Arfeuille, Chloe
    Delaugerre, Constance
    Chaix-Baudier, Marie-Laure
    Naudin, Jerome
    Auvin, Stephane
    Bergaoui, Karim
    Merlat-Guitard, Anne-Isabelle
    De Jorna, Romain
    Mebarki, Miryam
    Dalle, Jean-Hugues
    Baruchel, Andre
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 373 - 377
  • [3] CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report
    Wen, Shupeng
    Niu, Zhiyun
    Xing, Lina
    Wang, Ying
    Li, Hang
    Kuang, Na
    Luo, Jianmin
    Zhang, Xuejun
    Wang, Fuxu
    BMC CANCER, 2018, 18
  • [4] CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report
    Shupeng Wen
    Zhiyun Niu
    Lina Xing
    Ying Wang
    Hang Li
    Na Kuang
    Jianmin Luo
    Xuejun Zhang
    Fuxu Wang
    BMC Cancer, 18
  • [5] Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    马润芝
    China Medical Abstracts(Internal Medicine), 2021, 38 (04) : 228 - 229
  • [6] Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation
    Zhang, Rongli
    He, Yi
    Yang, Donglin
    Wang, Ying
    Feng, Sizhou
    Wang, Jianxiang
    Han, Ming-Zhe
    BLOOD, 2018, 132
  • [7] CD19 Targeted CAR-T Therapy Followed by Haploidentical HSCT for Refractory/Relapsed Acute Leukemia: Superior Therapeutic Efficacy
    Hu Yongxian
    Luo Yi
    Shi Jimin
    Yu Jian
    Wei Guoqing
    Wu Wenjun
    Wu Zhao
    Xiao Lei
    Huang He
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S231 - S231
  • [8] Allo-CD19-CAR-T Therapy followed by Allo-HSCT with the same donor to treat refractory or relapsed B-ALL
    Zhang Jian-Ping
    Yang Jun-Fang
    Li Nan-Nan
    Fan Li-Jun
    Gao Xin-Xia
    Chang Lung-Ji
    Lu Xin-An
    Lu Pei-Hua
    BONE MARROW TRANSPLANTATION, 2018, 53 : 385 - 385
  • [9] Efficacy and risk of donor-derived CAR-T treatment of relapsed B-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation
    Deng, Lei
    Yu, Xiaolin
    Song, Xiaocheng
    Guan, Rui
    Li, Wenjun
    Hou, Yixi
    Shao, Yan
    Zhao, Yuerong
    Wang, Jing
    Liu, Yue
    Xiao, Qianqian
    Xin, Bo
    Zhou, Fang
    CYTOTHERAPY, 2024, 26 (11) : 1301 - 1307
  • [10] Donor-Derived Sleeping Beauty Engineered CAR CD19 Cells for B-Acute Leukemia
    Magnani, Chiara
    Mezzanotte, Claudia
    Capuzzello, Claudia
    Benedicenti, Fabrizio
    Benedicenti, Andrea
    Fazio, Grazia
    Cazzaniga, Gianni
    Montini, Eugenio
    Gaipa, Giuseppe
    Biondi, Andrea
    Biagi, Ettore
    MOLECULAR THERAPY, 2017, 25 (05) : 355 - 355
12345